Abstract
Receptors are the essential molecular gatekeepers of life, governing the flow of information across biological membranes. While we introduce the receptor concept across its major structural classes, we focus thereafter on G-protein-coupled receptors (GPCRs) as the principal exemplar — the largest and most extensively drugged and structurally characterized receptor superfamily. This review traces the evolution of the receptor concept, from the early “side-chain” hypotheses to the modern realization of receptors as dynamic probabilistic molecular machines. By mapping the transition from pharmacological characterization to atomic-level visualization, we demonstrate how dissecting receptor function has transformed molecular biology and our understanding of signal transduction. We explore the molecular architecture of disease, highlighting how mechanical failures in these relays drive pathologies ranging from oncogenic transformations and channelopathies to the sophisticated hijacking of receptors by viral pathogens. As these insights reveal the limitations of traditional, static drug design, we must pivot toward approaches that actively manipulate receptor life cycles and signalling kinetics. Furthermore, we examine the shifting paradigm in drug discovery, moving beyond simple occupancy toward event-driven modalities such as targeted protein degradation and kinetic selectivity. Crucially, we discuss the recent structural revolution fuelled by the Cryo-EM and the integration of Artificial Intelligence in decoding the dark GPCRome. Finally, we look beyond the cell to the emerging role of receptors as programmable bio-hardware in diagnosis and synthetic biology. This comprehensive overview offers new insights into these molecular machineries and provides a roadmap for the future of precision medicine and bio-digital integration.